317 related articles for article (PubMed ID: 34332992)
21. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
[TBL] [Abstract][Full Text] [Related]
22. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
23. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test.
Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934
[TBL] [Abstract][Full Text] [Related]
24. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
[TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
27. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
Naumov VA; Generozov EV; Zaharjevskaya NB; Matushkina DS; Larin AK; Chernyshov SV; Alekseev MV; Shelygin YA; Govorun VM
Epigenetics; 2013 Sep; 8(9):921-34. PubMed ID: 23867710
[TBL] [Abstract][Full Text] [Related]
28. Uncovering potential genes in colorectal cancer based on integrated and DNA methylation analysis in the gene expression omnibus database.
Wang G; Wang F; Meng Z; Wang N; Zhou C; Zhang J; Zhao L; Wang G; Shan B
BMC Cancer; 2022 Feb; 22(1):138. PubMed ID: 35114976
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation status as a biomarker of anti-epidermal growth factor receptor treatment for metastatic colorectal cancer.
Ouchi K; Takahashi S; Yamada Y; Tsuji S; Tatsuno K; Takahashi H; Takahashi N; Takahashi M; Shimodaira H; Aburatani H; Ishioka C
Cancer Sci; 2015 Dec; 106(12):1722-9. PubMed ID: 26426205
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.
Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX
Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777
[TBL] [Abstract][Full Text] [Related]
31. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
32. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
Kano H; Takayama T; Midorikawa Y; Nagase H
Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
[TBL] [Abstract][Full Text] [Related]
33. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
[TBL] [Abstract][Full Text] [Related]
34. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
36. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
38. Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer.
Hauptman N; Jevšinek Skok D; Spasovska E; Boštjančič E; Glavač D
BMC Med Genomics; 2019 Apr; 12(1):54. PubMed ID: 30987631
[TBL] [Abstract][Full Text] [Related]
39. A novel discriminating colorectal cancer model for differentiating normal and tumor tissues.
Sun X; Tian Y; Zheng Q; Zheng R; Lin A; Chen T; Zhu Y; Lai M
Epigenomics; 2018 Nov; 10(11):1463-1475. PubMed ID: 30324808
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients.
Fang WJ; Zheng Y; Wu LM; Ke QH; Shen H; Yuan Y; Zheng SS
Asian Pac J Cancer Prev; 2012; 13(5):1917-21. PubMed ID: 22901147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
